Perioperative Management of Endocrine Hypertension

  • Peter Hambly


Many endocrine disorders are recognised causes of hypertension (Fig. 31.1). In terms of perioperative management, such conditions fall into two groups:
  1. 1.

    Those in which hypertension is managed with a standard approach, as used for patients with non-endocrine hypertension.

  2. 2.

    Those in which special interventions are required.



  1. 1.
    Hartle A, McCormack T, et al. The measurement of adult blood pressure and management of hypertension before elective surgery. Anaesthesia. 2016;71:326–37.CrossRefGoogle Scholar
  2. 2.
    Ahmed I, Jepegnanam C. Recognition and management of Phaeochromocytoma. Anaesth Intens Care Med. 2015;10:465–9.Google Scholar
  3. 3.
    Herrera MF, Stone E, et al. Pheochromocytoma producing multiple vasoactive peptides. Archiv Surg. 1992;127(1):105–8.CrossRefGoogle Scholar
  4. 4.
    Connor D, Boumphrey S. Perioperative care of phaeochromocytoma. BJA Educ. 2015;16(5):153–8.CrossRefGoogle Scholar
  5. 5.
    Lentschener C, Gaujoux S, et al. Point of controversy: perioperative care of patients undergoing phaeochromocytoma removal – time for reappraisal? Eur J Endocrinol. 2011;165:365–73.CrossRefGoogle Scholar
  6. 6.
    Phenoxybenzamine versus Doxazosin in PCC Patients (PRESCRIPT).
  7. 7.
    Boutros AR, Bravo EL etc al. Perioperative management of 63 patients with phaeochromocytoma. Cleve Clin J Med 1990; 57: 613-617.CrossRefGoogle Scholar
  8. 8.
    Roth JV. Use of vasopressin bolus and infusion to treat catecholamine-resistant hypotension during phaeochromocytoma resection. Anaesthesiology. 2007;106(4):883–4.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Singapore 2018

Authors and Affiliations

  • Peter Hambly
    • 1
  1. 1.Oxford University Hospitals NHS TrustOxfordUK

Personalised recommendations